Since the success of the COVID-19 vaccine, RNA therapies have been the object of increasing interest in the biotech world. These therapies work with your body to target the genetic root of diseases and infections, a promising alternative treatment method to that of traditional pharmaceutical drugs.
Click here for original story, RNA lipid nanoparticle engineering stops liver fibrosis in its tracks, reverses damage
Source: Phys.org